Quantification revealed significantly increased proportions of CEA−/lo cells in poorly differentiated CRC tumors compared to well/moderately differentiated CRC tumors (Figure 2B and Supplementary Table S1). This evidence concerns the gene CEACAM5 and colorectal carcinoma.